3.785

2.45% -0.095

Rocket Pharmaceuticals Inc (RCKT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$3.88

Offen:

$3.9

24-Stunden-Volumen:

272.95K

Relative Volume:

0.12

Marktkapitalisierung:

$409.08M

Einnahmen:

Nettoeinkommen (Verlust:

$-258.08M

KGV:

-1.3764

EPS:

-2.75

Netto-Cashflow:

$-202.32M

1W Leistung:

+9.39%

1M Leistung:

+12.65%

6M Leistung:

+18.28%

1J Leistung:

-67.90%

1-Tages-Spanne:

$3.775

$4.00

1-Wochen-Bereich:

$3.454

$4.05

52-Wochen-Spanne:

$2.19

$11.68

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Firmenname

Rocket Pharmaceuticals Inc

Sektor

Healthcare (1117)

Branche

Biotechnology (621)

Telefon

646-440-9100

Adresse

350 FIFTH AVENUE, NEW YORK, NY

Mitarbeiter

299

Twitter

@rocketpharma

Nächster Verdiensttermin

2024-11-04

Neueste SEC-Einreichungen

RCKT's Discussions on Twitter

Vergleichen Sie RCKT mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RCKT Rocket Pharmaceuticals Inc	3.78	419.90M	0	-258.08M	-202.32M	-2.75
VRTX Vertex Pharmaceuticals Inc	471.37	119.17B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	810.29	84.19B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	408.64	52.77B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	814.78	48.98B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.34	36.31B	447.02M	-1.18B	-906.14M	-6.1812

Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-18	Herabstufung	JP Morgan	Neutral → Underweight
2025-08-20	Hochstufung	BofA Securities	Neutral → Buy
2025-07-25	Herabstufung	BofA Securities	Buy → Neutral
2025-05-30	Herabstufung	Evercore ISI	Outperform → In-line
2025-05-28	Herabstufung	Goldman	Neutral → Sell
2025-05-28	Herabstufung	JP Morgan	Overweight → Neutral
2025-05-28	Herabstufung	Jefferies	Buy → Hold
2025-05-28	Herabstufung	Leerink Partners	Outperform → Market Perform
2025-05-28	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-05-27	Herabstufung	Needham	Buy → Hold
2025-05-27	Herabstufung	TD Cowen	Buy → Hold
2025-03-12	Eingeleitet	BMO Capital Markets	Outperform
2024-12-30	Eingeleitet	Wedbush	Outperform
2024-12-18	Eingeleitet	Jefferies	Buy
2024-10-16	Eingeleitet	Scotiabank	Sector Outperform
2024-04-02	Eingeleitet	Goldman	Neutral
2023-10-24	Eingeleitet	Cantor Fitzgerald	Overweight
2023-02-01	Eingeleitet	Morgan Stanley	Overweight
2022-11-08	Eingeleitet	Canaccord Genuity	Buy
2022-11-01	Eingeleitet	BTIG Research	Buy
2022-07-08	Eingeleitet	Raymond James	Outperform
2021-10-20	Fortgesetzt	Cowen	Outperform
2021-03-02	Eingeleitet	Stifel	Buy
2021-02-18	Eingeleitet	Needham	Buy
2020-12-16	Eingeleitet	UBS	Buy
2020-12-08	Herabstufung	Oppenheimer	Outperform → Perform
2020-07-02	Eingeleitet	JP Morgan	Overweight
2020-06-25	Fortgesetzt	BofA/Merrill	Buy
2020-06-01	Fortgesetzt	Oppenheimer	Outperform
2019-11-06	Eingeleitet	Chardan Capital Markets	Buy
2019-09-26	Eingeleitet	Piper Jaffray	Overweight
2019-04-23	Eingeleitet	Robert W. Baird	Outperform
2019-03-15	Eingeleitet	BofA/Merrill	Buy
2019-02-05	Eingeleitet	Oppenheimer	Outperform
2018-09-13	Eingeleitet	Ladenburg Thalmann	Buy
2018-07-10	Eingeleitet	William Blair	Outperform

Alle ansehen

Rocket Pharmaceuticals Inc Aktie (RCKT) Neueste Nachrichten

Jan 08, 2026

How Rocket Pharmaceuticals Inc. Equity Warrant stock performs in weak economySector Leadership Analysis & Small Capital Trading Growth - bollywoodhelpline.com

Jan 08, 2026

Why Rocket Pharmaceuticals Inc. stock could outperform in 2025Take Profit & Short-Term Swing Trade Alerts - ulpravda.ru

Jan 08, 2026

How rising interest rates impact Rocket Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Smart Allocation Stock Tips - ulpravda.ru

Jan 08, 2026

Jan 07, 2026

What is the fair value of Rocket Pharmaceuticals Inc. stock nowEquity Performance Review & High Return Portfolio Growth - ulpravda.ru

Jan 07, 2026

Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentumTrading Volume Trends & Superior Growth Trading - ulpravda.ru

Jan 07, 2026

Jan 05, 2026

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 05, 2026

Jan 02, 2026

What analysts say about Rocket Pharmaceuticals Inc stockPortfolio Risk Assessment & Double Or Triple Capital - earlytimes.in

Jan 02, 2026

Dec 31, 2025

The Truth About Rocket Pharmaceuticals: Is RCKT About To Explode Or Crash? - AD HOC NEWS

Dec 31, 2025

Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Cross Below 50 Day Moving AverageShould You Sell? - MarketBeat

Dec 31, 2025

Dec 27, 2025

Can Rocket Pharmaceuticals Inc. Equity Warrant stock maintain growth trajectoryHigh Yield Income Stocks & Connect With Bulls, Avoid the Bears - bollywoodhelpline.com

Dec 27, 2025

Dec 26, 2025

Rocket Pharmaceuticals: Upside On LAD-I Approval And Amended Danon Program - Seeking Alpha

Dec 26, 2025

Is Rocket Pharmaceuticals (RCKT) One of the Best NASDAQ Stocks Under $5 to Buy Now? - MSN

Dec 26, 2025

Dec 23, 2025

Published on: 2025-12-24 06:58:20 - earlytimes.in

Dec 23, 2025

Dec 20, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock remain a Wall Street favoriteWeekly Profit Analysis & Long Hold Capital Preservation Plans - Улправда

Dec 20, 2025

How buybacks impact Rocket Pharmaceuticals Inc. stock valueMarket Rally & Expert Approved Momentum Trade Ideas - Улправда

Dec 20, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock outperform Nasdaq indexJuly 2025 Weekly Recap & Daily Entry Point Alerts - Bölüm Sonu Canavarı

Dec 20, 2025

Is Rocket Pharmaceuticals Inc. Equity Warrant stock dividend yield sustainableJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

Can Rocket Pharmaceuticals Inc. Equity Warrant stock sustain institutional interest2025 Breakouts & Breakdowns & Weekly Top Performers Watchlists - Улправда

Dec 19, 2025

Can Rocket Pharmaceuticals Inc. stock hit analyst price targetsMarket Risk Report & Daily Entry Point Alerts - Улправда

Dec 19, 2025

What margin trends mean for Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Pullbacks & Real-Time Volume Spike Alerts - Улправда

Dec 19, 2025

Published on: 2025-12-19 17:54:30 - DonanımHaber

Dec 19, 2025

Will Rocket Pharmaceuticals Inc. stock rally after Fed decisions2025 Retail Activity & Long-Term Growth Portfolio Plans - DonanımHaber

Dec 19, 2025

Will Rocket Pharmaceuticals Inc. Equity Warrant stock maintain dividend yieldJuly 2025 Levels & Safe Swing Trade Setups - DonanımHaber

Dec 19, 2025

Stop Loss: Will Rocket Pharmaceuticals Inc. Equity Warrant stock rally after Fed decisionsWeekly Risk Report & Verified Short-Term Trading Plans - DonanımHaber

Dec 19, 2025

Rally Mode: What is the fair value of Rocket Pharmaceuticals Inc. stock nowJuly 2025 WrapUp & Low Drawdown Trading Techniques - ulpravda.ru

Dec 19, 2025

Dec 18, 2025

Why analysts remain bullish on Rocket Pharmaceuticals Inc. stockWeekly Trade Report & High Accuracy Trade Alerts - Улправда

Dec 18, 2025

Published on: 2025-12-18 21:01:52 - Улправда

Dec 18, 2025

Published on: 2025-12-18 16:59:15 - Улправда

Dec 18, 2025

Market Fear: Will Rocket Pharmaceuticals Inc. Equity Warrant stock continue upward momentum2025 Market Overview & Intraday High Probability Alerts - Улправда

Dec 18, 2025

Published on: 2025-12-18 16:13:14 - Улправда

Dec 18, 2025

Dec 17, 2025

Rocket Pharmaceuticals Leads Our Trio Of Penny Stock Contenders - Yahoo Finance

Dec 17, 2025

Dec 16, 2025

Analysts Are Bullish on Top Healthcare Stocks: Novan (NOVN), Palvella Therapeutics (PVLA) - The Globe and Mail

Dec 16, 2025

Rocket Pharmaceuticals (RCKT) Stock Target Reduced Following Q3 2025 Update on Cash Position - Finviz

Dec 16, 2025

Dec 14, 2025